These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 15451797
1. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats. Bourraindeloup M, Adamy C, Candiani G, Cailleret M, Bourin MC, Badoual T, Su JB, Adubeiro S, Roudot-Thoraval F, Dubois-Rande JL, Hittinger L, Pecker F. Circulation; 2004 Oct 05; 110(14):2003-9. PubMed ID: 15451797 [Abstract] [Full Text] [Related]
2. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril. Bernátová I, Pechánová O, Pelouch V, Simko F. J Mol Cell Cardiol; 2000 Feb 05; 32(2):177-85. PubMed ID: 10722795 [Abstract] [Full Text] [Related]
3. Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats. Adamy C, Mulder P, Khouzami L, Andrieu-abadie N, Defer N, Candiani G, Pavoine C, Caramelle P, Souktani R, Le Corvoisier P, Perier M, Kirsch M, Damy T, Berdeaux A, Levade T, Thuillez C, Hittinger L, Pecker F. J Mol Cell Cardiol; 2007 Sep 05; 43(3):344-53. PubMed ID: 17707397 [Abstract] [Full Text] [Related]
4. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension. Bunbupha S, Prachaney P, Kukongviriyapan U, Kukongviriyapan V, Welbat JU, Pakdeechote P. Clin Exp Pharmacol Physiol; 2015 Nov 05; 42(11):1189-97. PubMed ID: 26234646 [Abstract] [Full Text] [Related]
5. N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster. Matsuhisa S, Otani H, Okazaki T, Yamashita K, Akita Y, Sato D, Moriguchi A, Iwasaka T. Antioxid Redox Signal; 2008 Dec 05; 10(12):1999-2008. PubMed ID: 18665799 [Abstract] [Full Text] [Related]
8. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Sainz J, Wangensteen R, Rodríguez Gómez I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F. Am J Hypertens; 2005 Jun 05; 18(6):871-7. PubMed ID: 15925750 [Abstract] [Full Text] [Related]
11. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Rauchová H, Pechánová O, Kunes J, Vokurková M, Dobesová Z, Zicha J. Hypertens Res; 2005 May 05; 28(5):475-82. PubMed ID: 16156512 [Abstract] [Full Text] [Related]
14. Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling. Li W, Gan R, Sun G. Chin Med J (Engl); 2002 Aug 05; 115(8):1166-9. PubMed ID: 12215284 [Abstract] [Full Text] [Related]
15. Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2. Jin L, Lin MQ, Piao ZH, Cho JY, Kim GR, Choi SY, Ryu Y, Sun S, Kee HJ, Jeong MH. J Hypertens; 2017 Jul 05; 35(7):1502-1512. PubMed ID: 28234674 [Abstract] [Full Text] [Related]